These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22475066)

  • 1. Analysis of a metalloporphyrin antioxidant mimetic (MnTE-2-PyP) as a radiomitigator: prostate tumor and immune status.
    Mehrotra S; Pecaut MJ; Freeman TL; Crapo JD; Rizvi A; Luo-Owen X; Slater JM; Gridley DS
    Technol Cancer Res Treat; 2012 Oct; 11(5):447-57. PubMed ID: 22475066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a metalloporphyrin antioxidant (MnTE-2-PyP) on the response of a mouse prostate cancer model to radiation.
    Makinde AY; Luo-Owen X; Rizvi A; Crapo JD; Pearlstein RD; Slater JM; Gridley DS
    Anticancer Res; 2009 Jan; 29(1):107-18. PubMed ID: 19331139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A metalloporphyrin antioxidant alters cytokine responses after irradiation in a prostate tumor model.
    Makinde AY; Rizvi A; Crapo JD; Pearlstein RD; Slater JM; Gridley DS
    Radiat Res; 2010 Apr; 173(4):441-52. PubMed ID: 20334516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superoxide dismutase mimic, MnTE-2-PyP(5+) ameliorates acute and chronic proctitis following focal proton irradiation of the rat rectum.
    Archambeau JO; Tovmasyan A; Pearlstein RD; Crapo JD; Batinic-Haberle I
    Redox Biol; 2013; 1(1):599-607. PubMed ID: 24363995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A manganese porphyrin superoxide dismutase mimetic enhances tumor radioresponsiveness.
    Moeller BJ; Batinic-Haberle I; Spasojevic I; Rabbani ZN; Anscher MS; Vujaskovic Z; Dewhirst MW
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):545-52. PubMed ID: 16168847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust rat pulmonary radioprotection by a lipophilic Mn N-alkylpyridylporphyrin, MnTnHex-2-PyP(5+).
    Gauter-Fleckenstein B; Reboucas JS; Fleckenstein K; Tovmasyan A; Owzar K; Jiang C; Batinic-Haberle I; Vujaskovic Z
    Redox Biol; 2014; 2():400-10. PubMed ID: 24624330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioprotective effect of a metalloporphyrin compound in rat eye model.
    Mao XW; Crapo JD; Mekonnen T; Lindsey N; Martinez P; Gridley DS; Slater JM
    Curr Eye Res; 2009 Jan; 34(1):62-72. PubMed ID: 19172472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection from delayed postischemic administration of a metalloporphyrin catalytic antioxidant.
    Mackensen GB; Patel M; Sheng H; Calvi CL; Batinic-Haberle I; Day BJ; Liang LP; Fridovich I; Crapo JD; Pearlstein RD; Warner DS
    J Neurosci; 2001 Jul; 21(13):4582-92. PubMed ID: 11425886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MnTE-2-PyP reduces prostate cancer growth and metastasis by suppressing p300 activity and p300/HIF-1/CREB binding to the promoter region of the PAI-1 gene.
    Tong Q; Weaver MR; Kosmacek EA; O'Connor BP; Harmacek L; Venkataraman S; Oberley-Deegan RE
    Free Radic Biol Med; 2016 May; 94():185-94. PubMed ID: 26944191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation and a metalloporphyrin radioprotectant in a mouse prostate tumor model.
    Gridley DS; Makinde AY; Luo X; Rizvi A; Crapo JD; Dewhirst MW; Moeller BJ; Pearlstein RD; Slater JM
    Anticancer Res; 2007; 27(5A):3101-9. PubMed ID: 17970050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mn-porphyrins as novel molecular magnetic resonance imaging contrast agents.
    Mouraviev V; Venkatraman TN; Tovmasyan A; Kimura M; Tsivian M; Mouravieva V; Polascik TJ; Wang H; Amrhein TJ; Batinic-Haberle I; Lascola C
    J Endourol; 2011 Nov; ():1420-4. PubMed ID: 22050509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mn porphyrins as novel molecular magnetic resonance imaging contrast agents.
    Mouraviev V; Venkatraman TN; Tovmasyan A; Kimura M; Tsivian M; Mouravieva V; Polascik TJ; Wang H; Amrhein TJ; Batinic-Haberle I; Lascola C
    J Endourol; 2012 Nov; 26(11):1420-4. PubMed ID: 22783812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MnTE-2-PyP Treatment, or NOX4 Inhibition, Protects against Radiation-Induced Damage in Mouse Primary Prostate Fibroblasts by Inhibiting the TGF-Beta 1 Signaling Pathway.
    Chatterjee A; Kosmacek EA; Oberley-Deegan RE
    Radiat Res; 2017 Mar; 187(3):367-381. PubMed ID: 28225655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term administration of a small molecular weight catalytic metalloporphyrin antioxidant, AEOL 10150, protects lungs from radiation-induced injury.
    Rabbani ZN; Batinic-Haberle I; Anscher MS; Huang J; Day BJ; Alexander E; Dewhirst MW; Vujaskovic Z
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):573-80. PubMed ID: 17236973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer therapeutic potential of Mn porphyrin/ascorbate system.
    Tovmasyan A; Sampaio RS; Boss MK; Bueno-Janice JC; Bader BH; Thomas M; Reboucas JS; Orr M; Chandler JD; Go YM; Jones DP; Venkatraman TN; Haberle S; Kyui N; Lascola CD; Dewhirst MW; Spasojevic I; Benov L; Batinic-Haberle I
    Free Radic Biol Med; 2015 Dec; 89():1231-47. PubMed ID: 26496207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nonclinical safety assessment of MnTE-2-PyP, a manganese porphyrin.
    Gad SC; Sullivan DW; Crapo JD; Spainhour CB
    Int J Toxicol; 2013 Jul; 32(4):274-87. PubMed ID: 23704100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early and late administration of MnTE-2-PyP5+ in mitigation and treatment of radiation-induced lung damage.
    Gauter-Fleckenstein B; Fleckenstein K; Owzar K; Jiang C; Rebouças JS; Batinic-Haberle I; Vujaskovic Z
    Free Radic Biol Med; 2010 Apr; 48(8):1034-43. PubMed ID: 20096348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New class of potent catalysts of O2.-dismutation. Mn(III) ortho-methoxyethylpyridyl- and di-ortho-methoxyethylimidazolylporphyrins.
    Batinić-Haberle I; Spasojević I; Stevens RD; Hambright P; Neta P; Okado-Matsumoto A; Fridovich I
    Dalton Trans; 2004 Jun; (11):1696-702. PubMed ID: 15252564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiangiogenic action of redox-modulating Mn(III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin, MnTE-2-PyP(5+), via suppression of oxidative stress in a mouse model of breast tumor.
    Rabbani ZN; Spasojevic I; Zhang X; Moeller BJ; Haberle S; Vasquez-Vivar J; Dewhirst MW; Vujaskovic Z; Batinic-Haberle I
    Free Radic Biol Med; 2009 Oct; 47(7):992-1004. PubMed ID: 19591920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of potent Mn porphyrin-based SOD mimics and peroxynitrite scavengers for pre-clinical mechanistic/therapeutic purposes.
    Rebouças JS; Spasojević I; Batinić-Haberle I
    J Pharm Biomed Anal; 2008 Nov; 48(3):1046-9. PubMed ID: 18804338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.